top of page
Home
Technology
Pipeline
Female Stress Urinary Incontinence
About Us
Open Positions
Investors & Media
Contact
More...
Use tab to navigate through the menu items.
ALL POSTS
NEWS
MEDIA
RESOURCES
AWARDS
PUBLICATIONS
Search
MUVON Therapeutics announces appointments to its Advisory Board.
MUVON Therapeutics announces the appointment of Dorothea Ledergerber, PhD, and Christoph Herwig, PhD to its Advisory Board.
Oct 28, 2024
2 min read
Article published in Nature Reviews Bioengineering
We are delighted to announce that our latest paper has been published in Nature Reviews Bioengineering: Down to Business. The paper dives...
Sep 19, 2024
1 min read
MUVON ranked as a top 3 Biotech and overall 18th in 2024s TOP 100 Swiss Startups ranking
MUVON ranked as a top 3 Biotech and overall 18th in 2024s TOP 100 Swiss Startups ranking
Sep 5, 2024
1 min read
INVEST IN OUR
INNOVATION
MORE INFORMATION
Invest in us to be part of a groundbreaking journey toward innovative, life-changing muscle regeneration therapies, addressing a massive global market with scalable solutions.
bottom of page
